Pfizer 4 jun 2026 Moderna Outshines Pharma Giants Lilly, Merck and Pfizer With 43% Year-to-Date Surge - NAI500
Pfizer 3 jun 2026 Meet the Biotech Stock That's Trouncing Lilly, Merck, and Pfizer in 2026 - Yahoo Finance
Pfizer 30 may 2026 ASCO: In next-gen IO race, BioNTech/BMS and Pfizer are divided on overall survival approach - Fierce Biotech
Pfizer 30 may 2026 ASCO: Pfizer one-ups J&J with Talzenna combo's broad castration-sensitive prostate cancer win - Fierce Pharma
Pfizer 20 may 2026 Pharma sector doubles down on AI amid hopes of slashing costs, timelines - Reuters
Pfizer 20 may 2026 Pfizer’s next-gen pneumonia shot beats Prevnar 20; Relay targets $175M - Endpoints News
Pfizer 20 may 2026 Pfizer takes paediatric 25-valent pneumococcal vaccine to Phase III - FirstWord PHARMA
Pfizer 20 may 2026 Pfizer furthers pneumococcal efforts, remains ‘comfortable’ taking on emerging threats: vaccine chief - Fierce Biotech
Pfizer 15 may 2026 Michael Burry's Latest Buys Include a 6.66% Yielding Pharma Giant and an Oil Stock Up 46% This Year. Here Is Why - 24/7 Wall St.
Pfizer 14 may 2026 Should you buy pharma stocks? Dr Reddy's, Pfizer - Target prices after Q4 results - Business Today
Pfizer 12 may 2026 Pfizer, Arvinas win $85M upfront in Rigel licensing pact for new breast cancer med Veppanu - Fierce Pharma
Pfizer 12 may 2026 BridgeBio’s Attruby challenges Pfizer’s Vyndamax legacy in pivotal ATTR trial - Clinical Trials Arena
Pfizer 12 may 2026 Pfizer Ltd stock (INE182A01018): Indian pharma subsidiary eyes growth - AD HOC NEWS